Similar Search Results

Heterogeneity of patenting activity and its implications for scientific research

Czarnitzki, Dirk (contributor); … - 2007

The increasing commercialization of university discoveries has initiated a controversy on the impacts for future scientific research. It has been argued that an increasing orientation towards commercialization may have a negative impact on more fundamental research efforts in science. Several...

Persistent link: https://www.econbiz.de/10003479951

International R&D Spillovers : A Re-Examination

Lichtenberg, Frank R.; van Pottelsberghe de la … - 2021

Coe and Helpman(1995) have measured the extent to which technology spills over between industrialized countries through the particular channel of trade flows. This paper re-examines two particular features of their study. First, we suggest that their functional form of how foreign R&D affects...

Persistent link: https://www.econbiz.de/10013221859

R&D and Subsidies at the Firm Level: An Application of Parametric and Semi-Parametric Two-Step Selection Models

Hussinger, Katrin - 2003

This paper analyzes the effects of public R&D subsidies on R&D expenditure in the German manufacturing sector. The focus is on the question whether public R&D funding stimulates or crowds out private investment. Cross sectional data at the firm level is used. By apllying parametric and...

Persistent link: https://www.econbiz.de/10010297313

Spurious correlation in estimation of the health production function: A note

Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …

Persistent link: https://www.econbiz.de/10010285825

Spurious correlation in estimation of the health production function: A note

Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …

Persistent link: https://www.econbiz.de/10010315553

R&D and subsidies at the firm level : an application of parametric and semi-parametric two-step selection models

Hussinger, Katrin (contributor) - 2003

Persistent link: https://www.econbiz.de/10001911568

Spurious correlation in estimation of the health production function : a note

Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health … ; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration …

Persistent link: https://www.econbiz.de/10003900852

The contribution of pharmaceutical innovation to longevity growth in Germany and France

Lichtenberg, Frank R. - 2010

I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …

Persistent link: https://www.econbiz.de/10003977959

The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010 : evidence from longitudinal, disease-level data

Lichtenberg, Frank R.; Pettersson, Billie - 2012

We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

Persistent link: https://www.econbiz.de/10009571756

Spurious correlation in estimation of the health production function : a note

Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009

Persistent link: https://www.econbiz.de/10003909500